Jed Latkin | Chief Executive Officer, Chief Financial Officer and Chief Operating Officer |
Mike Rosol | Chief Medical Officer |
Erika Gibson | Director of Finance and Administration |
Michael Okunewitch | Maxim Group |
Vernon Bernardino | H.C. Wainwright |
Jacob Natowitz | Private Investor |
Mike Kelly | Private Investor |
Greeting and welcome to Navidea Biopharmaceuticals' Q2 2020 earnings and business update conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. Please note, this conference is being recorded.